Measurement of plasma oxidized low-density lipoprotein and its clinical implications.
about
Clinical Relevance of Biomarkers of Oxidative StressHidden disease susceptibility and sexual dimorphism in the heterozygous knockout of Cyp51 from cholesterol synthesisLOX-1 ligands containing apolipoprotein B and carotid intima-media thickness in middle-aged community-dwelling US Caucasian and Japanese men.Relation of circulating oxidized LDL to obesity and insulin resistance in childrenReactive oxygen species mediate oxidized low-density lipoprotein-induced inhibition of oct-4 expression and endothelial differentiation of bone marrow stem cells.The association between adiponectin, HDL-cholesterol and α1-antitrypsin-LDL in female subjects without metabolic syndromeThe Dynamics of Oxidized LDL during Atherogenesis.Cell membrane damage is involved in the impaired survival of bone marrow stem cells by oxidized low-density lipoproteinEffects of a 12-week healthy-life exercise program on oxidized low-density lipoprotein cholesterol and carotid intima-media thickness in obese elderly women.Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group StuGlycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis.Oxidized LDL signals through Rho-GTPase to induce endothelial cell stiffening and promote capillary formation.Circulating oxidized low-density lipoproteins are associated with overweight, obesity, and low serum carotenoids in older community-dwelling women.2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in AtherosclerosisSerum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.Oxidative modification of LDL: its pathological role in atherosclerosis.Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes.Absence of clinical relationship between oxidized low density lipoproteins and diabetic peripheral neuropathy: a case control study.Oxidized low density lipoprotein, stem cells, and atherosclerosis.Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitisOxidized low-density lipoprotein as a biomarker of cardiovascular diseases.OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation.Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.Oxidized low-density lipoprotein increases interleukin-8 production in human gingival epithelial cell line Ca9-22.Phosphatidylcholine hydroperoxide-induced THP-1 cell adhesion to intracellular adhesion molecule-1.Laminar shear stress regulates endothelial kinin B1 receptor expression and function: potential implication in atherogenesis.Automated measurement method for the determination of vitamin E in plasma lipoprotein classes.Oxidized low-density lipoprotein and tissue factor are involved in monocrotaline/lipopolysaccharide-induced hepatotoxicity.AFM investigation on Ox-LDL-induced changes in cell spreading and cell-surface adhesion property of endothelial cells.Proatherogenic Flow Increases Endothelial Stiffness via Enhanced CD36-Mediated Uptake of Oxidized Low-Density Lipoproteins.Gallic Acid Improves Health-Associated Biochemical Parameters and Prevents Oxidative Damage of DNA in Type 2 Diabetes Patients: Results of a Placebo-Controlled Pilot Study.oxLDL induces endothelial cell proliferation via Rho/ROCK/Akt/p27kip1 signaling: opposite effects of oxLDL and cholesterol loading.Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.High levels of iron status and oxidative stress in patients with metabolic syndrome.Lipoprotein oxidation biomarkers for cardiovascular risk: what does the future hold?Association between angiopoietin-like protein 2 and lectin-like oxidized low-density lipoprotein receptor 1 ligand containing apolipoprotein B in patients with type 2 diabetes
P2860
Q26785512-597E1AB8-2F9C-48C1-87A5-43CFE12DEC25Q27326039-1E5969D4-2561-4F4E-A32D-51BCD9AABF84Q30418436-1D461E6D-5C20-4C2A-8257-384CD9CC4EC0Q33939600-16F3C96F-A1BB-4016-AC4D-F3EF20885650Q34271579-F944F129-78B9-44A4-9E62-529C614B6549Q34478204-A1A0F4AC-B859-4B96-B540-C1D2C66E3D46Q35024665-B12C9D55-36C0-4DCF-8C74-E4909CB8A9BEQ35277772-4C67240E-EBAB-4DFD-880F-CB5B2368A4C4Q35789905-3BC9F901-AB1B-417C-A913-F315FB78C2F8Q36341298-5E649C4C-F293-4868-A726-92264D6D7934Q36755904-10E6D571-2CD4-4E95-AA6E-9FAD96A04891Q36843294-A0C36DA0-74CD-4D03-9486-9D93F6860B4FQ37129934-C78B030C-DE8E-4D17-8081-F23CB046428AQ37146276-418969D1-BA13-4575-A96E-86E826C5DA0FQ37294964-46AF5B0D-8858-4D8B-AA69-394AB65A145AQ37318786-1F67AE97-9671-4F25-A502-C405D24F66BEQ37361667-5725B0E2-020F-4B11-A43E-E289AFBEF1DDQ37600743-2AECCB11-C157-4E07-9B94-BC4F69A44D73Q38022767-620ADB77-8882-488B-AC91-01E29435A88CQ38026551-AC73C894-D9DB-4323-A237-C33AFA0C2984Q38299279-1EBC7F92-14F5-4AB0-961C-92A64C15CA9DQ39079743-5F5937E8-7462-4F3A-A71B-132CF97C99AAQ39153624-BFCEF932-D90D-436C-BDE8-1BC2510252EFQ39711825-85B5701A-EC3B-4D81-B031-1E4A0767EA27Q39900686-5299F8F9-F38A-403F-B8F9-126DF37217DBQ41882128-67352E92-861A-4DA3-972E-60C6BAC3C67DQ41952558-6EEDA2B4-F18E-453E-AD20-F4FF024D1EDEQ42753715-C9CA8C97-0D08-4B26-9069-CFAC0DF8A2A8Q47339736-4AD026C9-3125-4EA4-AA11-3F01EAF2367CQ47674812-68FF3774-7498-478F-97A3-E6F97F2AFF99Q49377852-B90B2DB9-8FB3-470F-B5C9-425AA048D441Q50894471-5C2CBC89-0936-40BB-8760-302CC77709F5Q51032319-A2395C5A-56C7-4868-BDB4-BDED1C5D0321Q51350120-E2714415-DDE3-4CF5-B013-EB554582DB23Q51614577-D4D1B5BB-48C1-45A6-AE8F-3E218D1D9270Q58692487-2CA984FC-A404-4D43-B05B-EE8622C75EEA
P2860
Measurement of plasma oxidized low-density lipoprotein and its clinical implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Measurement of plasma oxidized low-density lipoprotein and its clinical implications.
@en
type
label
Measurement of plasma oxidized low-density lipoprotein and its clinical implications.
@en
prefLabel
Measurement of plasma oxidized low-density lipoprotein and its clinical implications.
@en
P356
P1476
Measurement of plasma oxidized low-density lipoprotein and its clinical implications.
@en
P2093
Hiroyuki Itabe
Makiko Ueda
P356
10.5551/JAT.14.1
P577
2007-02-01T00:00:00Z